Cargando…

The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications

BACKGROUND: SARS-CoV-2 is an infectious virus, which has generated a global pandemic. Israel was one of the first countries to vaccinate its population, inaugurating the program on December 20, 2020. The objective of the current study is to investigate the projected daily COVID19 mortality growth ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbel, Yuval, Arbel, Yifat, Kerner, Amichai, Kerner, Miryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465668/
https://www.ncbi.nlm.nih.gov/pubmed/36096805
http://dx.doi.org/10.1186/s13584-022-00541-w
_version_ 1784787849916186624
author Arbel, Yuval
Arbel, Yifat
Kerner, Amichai
Kerner, Miryam
author_facet Arbel, Yuval
Arbel, Yifat
Kerner, Amichai
Kerner, Miryam
author_sort Arbel, Yuval
collection PubMed
description BACKGROUND: SARS-CoV-2 is an infectious virus, which has generated a global pandemic. Israel was one of the first countries to vaccinate its population, inaugurating the program on December 20, 2020. The objective of the current study is to investigate the projected daily COVID19 mortality growth rate with higher median age and population size of cities under two scenarios: with and without the BNT162b2 Pfizer vaccination against the SAR-COV2 virus. METHODS: This study employs a panel data-set. We follow the COVID19 mortality growth rate in each of the 173 Israeli cities and towns starting from March 21, 2020 (10 days after the first documentation of COVID19 cases in Israel) until September 21, 2021, where the BNT162b2 Pfizer vaccinations were available starting from December 20, 2020. RESULTS: Referring to the median age of municipal residents, findings suggest that the BNT162b2 Pfizer vaccinations attenuate the rise in anticipated daily mortality growth rate for cities and towns in which the median population age is 30 years old (the range in median age among the residents in the municipalities surveyed is 11–41 years). Moreover, referring to population size of cities, findings demonstrate that while under the scenario without vaccination, the daily mortality growth rate is anticipated to rise, under a comparable scenario with vaccination, daily mortality growth rate is anticipated to drop. CONCLUSIONS: In crowded cities, where the median age is high, two perspectives of early and intensive public policy interventions are clearly required. The first perspective is extensive medical treatment, namely, extension of availability of medical physical and online services; dispensing designated medications; expansion of hospitalization facilities and information services particularly to susceptible populations. All measures will be taken with attention to age accessibility of these means. The second perspective is prevention via establishment of testing and vaccination complexes; elevation of dedicated health services, generating selective lockdowns; education for increasing awareness to social distancing, wearing masks and other preventive means.
format Online
Article
Text
id pubmed-9465668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94656682022-09-12 The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications Arbel, Yuval Arbel, Yifat Kerner, Amichai Kerner, Miryam Isr J Health Policy Res Original Research Article BACKGROUND: SARS-CoV-2 is an infectious virus, which has generated a global pandemic. Israel was one of the first countries to vaccinate its population, inaugurating the program on December 20, 2020. The objective of the current study is to investigate the projected daily COVID19 mortality growth rate with higher median age and population size of cities under two scenarios: with and without the BNT162b2 Pfizer vaccination against the SAR-COV2 virus. METHODS: This study employs a panel data-set. We follow the COVID19 mortality growth rate in each of the 173 Israeli cities and towns starting from March 21, 2020 (10 days after the first documentation of COVID19 cases in Israel) until September 21, 2021, where the BNT162b2 Pfizer vaccinations were available starting from December 20, 2020. RESULTS: Referring to the median age of municipal residents, findings suggest that the BNT162b2 Pfizer vaccinations attenuate the rise in anticipated daily mortality growth rate for cities and towns in which the median population age is 30 years old (the range in median age among the residents in the municipalities surveyed is 11–41 years). Moreover, referring to population size of cities, findings demonstrate that while under the scenario without vaccination, the daily mortality growth rate is anticipated to rise, under a comparable scenario with vaccination, daily mortality growth rate is anticipated to drop. CONCLUSIONS: In crowded cities, where the median age is high, two perspectives of early and intensive public policy interventions are clearly required. The first perspective is extensive medical treatment, namely, extension of availability of medical physical and online services; dispensing designated medications; expansion of hospitalization facilities and information services particularly to susceptible populations. All measures will be taken with attention to age accessibility of these means. The second perspective is prevention via establishment of testing and vaccination complexes; elevation of dedicated health services, generating selective lockdowns; education for increasing awareness to social distancing, wearing masks and other preventive means. BioMed Central 2022-09-12 /pmc/articles/PMC9465668/ /pubmed/36096805 http://dx.doi.org/10.1186/s13584-022-00541-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Research Article
Arbel, Yuval
Arbel, Yifat
Kerner, Amichai
Kerner, Miryam
The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title_full The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title_fullStr The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title_full_unstemmed The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title_short The median age of a city’s residents and population density influence COVID 19 mortality growth rates: policy implications
title_sort median age of a city’s residents and population density influence covid 19 mortality growth rates: policy implications
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465668/
https://www.ncbi.nlm.nih.gov/pubmed/36096805
http://dx.doi.org/10.1186/s13584-022-00541-w
work_keys_str_mv AT arbelyuval themedianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT arbelyifat themedianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT kerneramichai themedianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT kernermiryam themedianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT arbelyuval medianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT arbelyifat medianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT kerneramichai medianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications
AT kernermiryam medianageofacitysresidentsandpopulationdensityinfluencecovid19mortalitygrowthratespolicyimplications